fda compounding semaglutide warning november 2025 issued 25 letters to telehealth companies for false and misleading claims about compounded GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of The FDA sent a warning

La mayora de nuestros pacientes tolera muy bien el tratamiento y, al finalizar la sesin, pueden retomar su actividad habitual inmediatamente

If retatrutide is approved on schedule, somewhere around 2027 a doctor will be able to prescribe the real thing, manufactured to pharmaceutical standards, with a label that reflects whatever the cardiovascular data show and a titration plan supervised by someone who can order an ECG

Data Privacy, Security, and Transparency Brello Health operates within a HIPAA-covered telehealth framework through affiliated medical provider groups

The results from the tail suspension test, as depicted in Figure 4, provide compelling evidence on the effects of different treatments on depressive-like behaviors in an animal model

These eating plans prioritize foods thought to support liver and kidney function